Highly active antiretroviral treatment and health related quality of life in South African adults with human immunodeficiency virus infection: A cross-sectional analytical study
2007

Impact of HIV Treatment on Quality of Life in South Africa

Sample size: 371 publication 10 minutes Evidence: moderate

Author Information

Author(s): Louwagie Goedele M, Bachmann Max O, Meyer Kobus, Booysen Frikkie le R, Fairall Lara R, Heunis Christo

Primary Institution: University of Pretoria

Hypothesis

Does Highly Active Antiretroviral Treatment (HAART) improve health-related quality of life (HRQoL) in HIV positive patients?

Conclusion

HAART was associated with improved HRQoL in patients enrolled in a public sector treatment program in South Africa.

Supporting Evidence

  • Patients receiving HAART reported better HRQoL for 3 of the 5 EuroQol dimensions.
  • Patients on HAART had a higher mean EuroQol index compared to those awaiting treatment.
  • Higher mean VAS scores were reported for patients receiving HAART.

Takeaway

People with HIV who are getting treatment feel better than those who are waiting for treatment.

Methodology

A cross-sectional interview survey was conducted with a stratified random sample of patients receiving or awaiting HAART, using the EuroQol questionnaire to measure HRQoL.

Potential Biases

As a non-randomized trial, the study could be biased by unmeasured confounders.

Limitations

The study was cross-sectional, which limits causal inferences, and treatment duration for many respondents was too short to fully capture HAART effects.

Participant Demographics

The sample included 371 patients, predominantly young (75% aged <43 years), with a higher proportion of women (65%) and largely unemployed (85%).

Statistical Information

P-Value

0.019

Confidence Interval

0.04; 0.23

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1471-2458-7-244

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication